Intelligence · Clinical pipeline
Autoimmune & immunology · Phase III
Autoimmune & immunology programs at Phase III — ClinicalTrials.gov pipeline intelligence.
Quick answer
Autoimmune & immunology Phase III programs: NovaPharmaNews indexes 368 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Takeda 39 programs
- Janssen-Cilag International N.V 26 programs
- Anaxis Pharma 20 programs
- AbbVie 18 programs
- Novartis India 17 programs
- AbbVie Deutschland GmbH 13 programs
- HOFFMANN-LA ROCHE 11 programs
- Eli Lilly and 9 programs
- Chinese Academy of 8 programs
- Bristol-Myers Squibb Australia 7 programs
- PARItec 7 programs
- Pacira Ireland 7 programs
Pipeline programs
-
Vyvgart 1 000 mg solution for injection
argenx
Generalized Myasthenia Gravis
1 trial -
Vyvgart 20 mg/mL concentrate for solution for infusion
argenx
Generalized Myasthenia Gravis
1 trial -
Vyvgart 20 mg/mL concentrate for solution for infusion
argenx
Generalized Myasthenia Gravis (gMG)
1 trial -
WN43174
Hoffmann-La Roche
NMDAR or LGI1 mediated autoimmune Encephalitis
1 trial -
Wobenzym® N
Atrium Therapeutics
Knee Osteoarthritis
1 trial -
ZASOCITINIB
Takeda
Moderate to Severe Plaque Psoriasis
1 trial -
ZILRETTA
Pacira Ireland Limited
Glenohumeral Osteoarthritis
1 trial -
Zasocitinib
Takeda
Plaque Psoriasis
2 trials -
Zasocitinib
Takeda
Psoriatic Arthritis
3 trials -
Zilucoplan sodium
Lacuna Pharma Pty Ltd
Generalized Myasthenia Gravis
1 trial -
bimekizumab
Lacuna Pharma Pty Ltd
Axial Spondyloarthritis
1 trial -
bimekizumab
Lacuna Pharma Pty Ltd
Active juvenile idiopathic arthritis subtypes enthesitis-related arthritis (including juvenile-onset ankylosing spondylitis) and juvenile psoriatic arthritis
1 trial -
bimekizumab
Lacuna Pharma Pty Ltd
Psoriatic Arthritis
1 trial -
blisibimod
Santhera Pharmaceuticals (Deutschland) GmbH
Systemic Lupus Erythematosus
1 trial -
bupivacaine liposome injectable suspension
Pacira Ireland Limited
Knee Osteoarthritis
1 trial -
dehydroepiandrosterone
Ultragenyx UK Limited
Systemic Lupus Erythematosus
3 trials -
hydroxychloroquine (Z0188)
Sanofi Pasteur
Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
1 trial -
ianalumab
Novartis Pharmaceuticals
Systemic Lupus Erythematosus
1 trial -
ianalumab s.c. q4w
Novartis Pharmaceuticals
Lupus Nephritis
1 trial -
mesalazine (Asacol®)
Cardiff Oncology
Ulcerative Colitis
1 trial -
mycophenolate mofetil (CellCept)
Hoffmann-La Roche
Myasthenia Gravis, Generalized
1 trial -
piclidenoson
Can-Fite BioPharma
Plaque Psoriasis
1 trial -
placebo for risankizumab
AbbVie
Crohn's Disease
1 trial -
placebo for risankizumab IV
AbbVie
Crohn's Disease
1 trial -
risankizumab
AbbVie
Ulcerative Colitis (UC)
1 trial -
risankizumab IV
AbbVie
Ulcerative Colitis (UC)
1 trial -
sarilumab SAR153191 (REGN88)
Regeneron UK Limited
Rheumatoid Arthritis
6 trials -
secukinumab
Novartis Pharmaceuticals
Lupus Nephritis
1 trial -
tacrolimus capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lupus Nephritis
1 trial -
tocilizumab [RoActemra/Actemra]
Hoffmann-La Roche
Rheumatoid Arthritis
3 trials -
total knee arthroplasty
Hospital Authority, Hong Kong
Osteoarthritis, Knee
1 trial -
voclosporin
Aurinia Pharmaceuticals
Psoriasis
3 trials
Frequently asked questions
How many autoimmune & immunology Phase III programs exist?
368 programs match both the therapeutic area and stage filters in our published index.